Selected Publications
Kim A. Reiss, MD; Sung Chul Hong, MS; Anup K. Kasi, MD; Eileen M. O’Reilly, MD; Shishir K Maithel, MD; Xin Yao, MD; Stanley R Hamilton, MD; Ben Boursi, MD; Michael J. Pishvaian, MD; Samuel J. Klempner, MD; Susan M. Domchek, MD; Paul Catalano, ScD; Elena G. Chiorean, MD; Philp A. Philip, MD; Peter J. O’Dwyer, MD: APOLLO: A Randomized Phase II Double-Blind Study of Olaparib versus Placebo Following Curative Intent Therapy in Patients with Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation: ECOG-ACRIN EA2192 ASCO GI, San Francisco, CA : 2023.
Timothy J Brown MD; Arielle Yablonovitch, PhD; Jennifer Yen, PhD; Lesli A. Kiedrowski, MS MPH; Erica Carpenter, PhD MBA; Katherine Nathanson, MD; Susan M. Domchek, MD and Kim A Reiss, MD: The identification of reversion mutations in patients with advanced pancreatic cancer and germline or somatic BRCA or PALB2 variants who were treated with maintenance rucaparib ASCO GI, San Francisco, CA : 2023.
William Chapin and Kim A. Reiss: PARP Inhibitors and Other Novel, Targeted Therapeutics in Pancreatic Adenocarcinoma. Hematology/Oncology Clinics of North America 36 (5): 1019-1032,2022.
Thomas B. Karasic, Timothy J Brown, Charles J. Schneider, Ursina R. Teitelbaum, Kim A. Reiss, Tara C. Mitchell, Ryan C. Massa, Mark H. O’Hara, Lisa DiCicco, Luis Garcia-Marcano, Ravi K. Amaravadi, Peter J O’Dwyer: Phase I Trial of Regorafenib, Hydroxychloroquine, and Entinostat in Metastatic Colorectal Cancer The Oncologist 27 (9): 716-e689,2022.
Kim A. Reiss; Rosemarie Mick; Ursina Teitelbaum; Mark O’Hara; Charles Schneider; Ryan Massa; Thomas Karasic; Rashmi Tondon; Chioma Onyiah; Mary Kate Gosselin; Alyssa Donze; Susan M. Domchek; Robert H. Vonderheide: Niraparib plus nivolumab or niraparib plus ipilimumab in patients with platinum-sensitive advanced pancreatic cancer: a randomised, phase Ib/II trial Lancet Oncology 23 (8): 1009-1020,2022.
William J. Chapin, MD, Jacob E. Till, MD, PhD, Wei-Ting Hwang, PhD, Jennifer R. Eads, MD, Thomas B. Karasic, MD, Peter J. O’Dwyer, MD, Charles J. Schneider, MD, Ursina R. Teitelbaum, MD, Janae Romeo, MBE, BA, Taylor A. Black, BA, Theresa E. Christensen, BA, Colleen Redlinger Tabery, BA, Amanda Anderson, PhD, Megan Slade, BS, Michael LaRiviere, MD, Stephanie S. Yee, MS, MBA, Kim A. Reiss, MD, Mark H. O’Hara, MD, Erica L. Carpenter, MBA, PhD: Multi-analyte prognostic signature including circulating tumor DNA and circulating tumor cells in patients with advanced pancreatic adenocarcinoma JCO Precision Oncology 6 : e2200060,2022.
Brennan Decker, Susan M. Domchek, Kate Nathanson, Shannon Bailey, Natalie Danziger, James Thornton, Mark Hartman, Chenming Cui1, Lei Yang, Smruthy Sivakumar, Russell Madison1, Ethan Sokol, Alexa B. Schrock, Bahar Yilmazel, Douglas A Mata, Christine Vietz, Jeffrey S. Ross, Julia A. Elvin, Geoffrey R. Oxnard, Kim A. Reiss: Landscape of homologous recombination reversion mutations in pancreaticobiliary malignancies
ASCO 2022, Chicago, IL : 2022.
Kim Anna Reiss, Yuan Yuan, Naoto T. Ueno, Melissa Lynne Johnson, Saar Gill, Elizabeth Claire Dees, Joseph Chao, Mathew Angelos, Olga Shestova, Jonathan Stuart Serody, Saul Priceman, Debora Barton, Ramona F. Swaby, Amy Ronczka, Thomas Condamine, Daniel Cushing, Rehman Qureshi, Madison Kemp, Michael Klichinsky, Yara Abdou: A phase 1, first-in-human (FIH) study of the anti-HER2 CAR macrophage CT-0508 in subjects with HER2 overexpressing solid tumors. ASCO 2022, Chicago, IL : 2022.
Kim A. Reiss, MD; Rosemarie Mick, MS; Ursina Teitelbaum, MD; Mark O’Hara, MD; Charles Schneider, MD; Ryan Massa, MD; Thomas Karasic, MD; Chioma Onyiah; Mary Kate Gosselin, RN; Alyssa Donze, RN; Susan M. Domchek, MD; Robert H. Vonderheide, MD, DPhil: A Randomized Phase Ib/II Study of Niraparib (Nira) plus Nivolumab (Nivo) or Ipilimumab (Ipi) in Patients (Pts) with Platinum-Sensitive Advanced Pancreatic Cancer (aPDAC) ASCO 2022, Chicago, IL : 2022.
Susan M. Domchek, Kim A. Reiss, Kate Nathanson, Shannon Bailey, Natalie Danziger, James Thornton, Mark Hartman, Chenming Cui, Lei Yang, Matthew Margolis, Erica Gornstein, Ethan Sokol, Douglas I. Lin, Alexa B. Schrock, Douglas A. Mata, Christine Vietz, Jeffrey S. Ross, Geoffrey R. Oxnard, Julia A. Elvin, Brennan Decker: Landscape of homologous recombination reversion mutations in gynecologic malignancies
ASCO 2022, Chicago, IL : 2022.
Academic Contact Information
Division of Hematology Oncology
Perelman Center for Advanced Medicine
10th Floor, South Pavilion
Office #10-305
3400 Civic Center Blvd
Philadelphia,
PA
19104
Phone: 215-360-0735
Patient appointments: 800-789-7366